Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (11-20 of 334) with videos related to

Pageof 34
Sort By:
Surgical Oncology Clinics of North America|November 21, 2007
Tumor microenvironment and immune escapeSoldano Ferrone, Theresa L Whiteside
Oncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano Ferrone
Advances in Cancer Research|November 13, 2010
Functional and clinical relevance of chondroitin sulfate proteoglycan 4Michael Campoli, Soldano Ferrone, Xinhui Wang
Immunological Investigations|March 14, 2017
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of ImmunotherapyCristina Maccalli, Giorgio Parmiani, Soldano Ferrone
Journal of Immunological Methods|September 6, 2003
Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulumTakeshi Ogino, Xinhui Wang, Soldano Ferrone
Trends in Immunology|January 28, 2003
HLA-G and MIC expression in tumors and their role in anti-tumor immunityBarbara Seliger, Hinrich Abken, Soldano Ferrone
Expert Opinion on Biological Therapy|June 8, 2018
Methods for improving the immunogenicity and efficacy of cancer vaccinesLorenzo Pilla, Soldano Ferrone, Cristina Maccalli
International Journal of Cancer|July 9, 2005
Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformationBarbara Seliger, Ulrike Ritz, Soldano Ferrone
International Archives of Allergy and Immunology|January 7, 2004
Immunotherapy of malignant diseases. Challenges and strategiesEric C Ko, Xinhui Wang, Soldano Ferrone
Advances in Cancer Research|March 31, 2005
Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directionsChien-Chung Chang, Michael Campoli, Soldano Ferrone
Pageof 34

Showing results (11-20 of 334) with videos related to

Sort By:
Pageof 34
Surgical Oncology Clinics of North America|November 21, 2007
Tumor microenvironment and immune escapeSoldano Ferrone, Theresa L Whiteside
Oncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano Ferrone
Advances in Cancer Research|November 13, 2010
Functional and clinical relevance of chondroitin sulfate proteoglycan 4Michael Campoli, Soldano Ferrone, Xinhui Wang
Immunological Investigations|March 14, 2017
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of ImmunotherapyCristina Maccalli, Giorgio Parmiani, Soldano Ferrone
Journal of Immunological Methods|September 6, 2003
Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulumTakeshi Ogino, Xinhui Wang, Soldano Ferrone
Trends in Immunology|January 28, 2003
HLA-G and MIC expression in tumors and their role in anti-tumor immunityBarbara Seliger, Hinrich Abken, Soldano Ferrone
Expert Opinion on Biological Therapy|June 8, 2018
Methods for improving the immunogenicity and efficacy of cancer vaccinesLorenzo Pilla, Soldano Ferrone, Cristina Maccalli
International Journal of Cancer|July 9, 2005
Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformationBarbara Seliger, Ulrike Ritz, Soldano Ferrone
International Archives of Allergy and Immunology|January 7, 2004
Immunotherapy of malignant diseases. Challenges and strategiesEric C Ko, Xinhui Wang, Soldano Ferrone
Advances in Cancer Research|March 31, 2005
Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directionsChien-Chung Chang, Michael Campoli, Soldano Ferrone
Pageof 34